New updates have been reported about BV Investment Partners.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
BV Investment Partners has acquired a majority interest in Moxe Health, positioning the private equity firm to deepen its exposure to tech-enabled healthcare data services and expand its portfolio in clinical interoperability. The deal, completed in partnership with Moxe’s CEO Mike Coyne, CFO/COO Katie Mallett, founder Dan Wilson, and the broader leadership team, is intended to fund the company’s next phase of network expansion, product development, and embedded EHR integrations.
For BV, the investment aligns with its strategy of backing scalable, tech-enabled business services platforms, particularly those addressing complex data and workflow challenges in regulated industries such as healthcare. Moxe’s EHR-neutral technology automates the exchange of clinical data between providers and health plans, reducing manual record retrieval and enabling payers to receive consistent, structured data to support payment, quality, and operational workflows, which BV views as a large and growing demand area.
By leveraging Moxe’s expanding connectivity across acute, ambulatory, independent, and specialty providers, BV expects to capitalize on the sector trend toward interoperability and administrative cost reduction, while benefiting from the fragmentation of healthcare IT that favors EHR-agnostic solutions. BV partner Sean Wilder described Moxe as a differentiated platform with trusted provider relationships and a scalable model for secure, automated data exchange, underscoring the firm’s thesis that the volume and velocity of clinical data will continue to rise and drive demand for infrastructure-like solutions.
Financial terms of the transaction were not disclosed, but BV’s involvement is likely to support increased investment in Moxe’s API-first capabilities, one-to-many EHR deployments, and governance frameworks that give providers control over data sharing, which should enhance the platform’s defensibility and long-term revenue potential. With more than $7.5 billion in assets under management and a track record of 50 investments under its current strategy, BV is using this majority stake to strengthen its position in healthcare technology, pursue value creation through operational scaling, and potentially build a platform for future add-on acquisitions or broader ecosystem partnerships around clinical data exchange.